Name:
Lacticaseibacillus brantae (Volokhov et al. 2012) Zheng et al. 2020
DSM No.:
23927, Type strain dsm-23927 dsm23927 dsm 23927 Lacticaseibacillus brantae
Strain designation:
SL1108
Other collection no.
or WDCM no.:
ATCC BAA-2142,LMG 26001
Isolated from:
feces of Canada goose ( Branta canadensis
Country:
United States of America
Maryland, Great Falls Park
Date of sampling:
01.06.2010
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- D. V. Volokhov, FDA; SL1108
Summary and
additional information:
<- D. V. Volokhov, FDA; SL1108. Feces of Canada goose ( Branta canadensis; USA, Maryland, Great Falls Park. Type strain. Taxonomy/description (17069, 38511). Sequence accession no. 16S rRNA gene: HQ022861, rpoB gene: HQ022858, whole genome shotgun sequence: AYZQ00000000. (Medium 11, 37°C, microaerophilic).
Risk group:
1 (classification according to German
TRBA)
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.
